Caixin
Feb 22, 2022 08:57 PM
CHINA

Hong Kong Can Stock Up on Anti-Covid Drugs to Tackle Omicron Outbreak, Top Infectious Disease Expert Says

Zhong Nanshan, academician of the Chinese Academy of Engineering and director of the National Clinical Research Center for Respiratory Disease. Photo: IC Photo
Zhong Nanshan, academician of the Chinese Academy of Engineering and director of the National Clinical Research Center for Respiratory Disease. Photo: IC Photo

China’s top infectious disease expert Zhong Nanshan has urged Hong Kong authorities to “put people’s lives and health first” in a Cantonese video message, where he shared recommendations for Hong Kong to contain its latest outbreak, including reserving anti-Covid drugs such as U.S. pharmaceutical giant Pfizer Inc.’s oral pill Paxlovid.

Hong Kong residents are facing the city’s worst-ever Covid-19 outbreak, which has overwhelmed its healthcare system and led the government to impose its toughest social-distancing rules.

loadingImg
You've accessed an article available only to subscribers
VIEW OPTIONS
Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
Caixin Deep Dive: Former Securities Regulator Yi Huiman’s Corruption Probe
00:00
00:00/00:00